| 000 | 01614nam a22004095a 4500 | ||
|---|---|---|---|
| 005 | 20250914164734.0 | ||
| 006 | m d | ||
| 007 | cr nn 008maaau | ||
| 008 | 090217s2005 nyu j eng d | ||
| 020 | _a9780387270807 (electronic bk.) | ||
| 020 | _a9780387202778 (paper) | ||
| 035 | _a(Springer)978-0-387-20277-8 | ||
| 039 | 9 |
_a200902171219 _bmuhaimin _c200902171200 _dmuhaimin _c200902021315 _dmuhaimin _c200809161820 _dmuhaimin _y04-03-2008 _zmuhaimin |
|
| 050 | 0 | 0 |
_aR853.C55 _bE935 2005 |
| 082 | 0 | 0 |
_a610.724 _222 |
| 090 |
_aR853.C55 _bE92 2005 |
||
| 245 | 0 | 4 |
_aThe Evaluation of Surrogate Endpoints _h[electronic resource] / _cedited by Tomasz Burzykowski, Geert Molenberghs, Marc Buyse. |
| 260 |
_aNew York, NY : _bSpringer Science+Business Media, Inc., _c2005. |
||
| 300 |
_axxiii, 408 p. : _bill., digital ; _c24 cm. |
||
| 440 | 0 |
_aStatistics for Biology and Health, _x1431-8776 |
|
| 650 | 0 | _aClinical trials. | |
| 650 | 0 |
_aDrugs _xTesting. |
|
| 650 | 1 | 4 | _aStatistics. |
| 650 | 2 | 4 | _aStatistics for Life Sciences, Medicine, Health Sciences. |
| 700 | 1 | _aBurzykowski, Tomasz. | |
| 700 | 1 | _aMolenberghs, Geert. | |
| 700 | 1 | _aBuyse, Marc. | |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer e-books | |
| 856 | 4 | 0 | _uhttps://eresourcesptsl.ukm.remotexs.co/login?url=http://dx.doi.org/10.1007/b138566 |
| 907 |
_a.b14116649 _b2022-04-06 _c2019-11-12 |
||
| 942 |
_n0 _kR853.C55 E92 2005 |
||
| 914 | _avtls003369095 | ||
| 998 |
_ae _b2008-03-04 _cm _dz _feng _gnyu _y0 _z.b14116649 |
||
| 999 |
_c407645 _d407645 |
||